Key facts
- It has raised $2.1M across 3 recorded rounds; the latest was Seed Round ($600K) in May 2024.
- Notable investors include Advanced Technology Development Center.
- Cathaid has filed 15 Form Ds with the SEC since 2020, most recently Feb 2025 ($600K sold to 19 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cathaid
Funding rounds
3 roundsAbout Cathaid
Developer of catheter protection devices designed to replace the standard of care with a simple-to-use system. The company's devices help to safeguard the catheter and detect positional shifts, enabling clinicians and medical professionals to use the medical device safely by reducing the risk of infection and complications.
- Sector
- Healthcare
- HQ
- GA
- Founded
- 2016
- Employees
- 3
- Website
- cathaid.com/
- Ownership
- Privately Held (backing)
Cathaid doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cathaid shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cathaid in its N-PORT filings yet. We sweep new filings monthly.